Unicycive Therapeutics, Inc.
UNCY
$4.19
-$0.0557-1.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.45M | 570.00K | -21.53M | -4.10M | 9.86M |
| Total Depreciation and Amortization | 138.00K | 135.00K | 134.00K | 123.00K | -113.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 197.00K | -7.79M | 13.14M | -1.15M | -16.17M |
| Change in Net Operating Assets | -2.31M | -1.82M | 1.70M | -4.13M | 108.00K |
| Cash from Operations | -8.42M | -8.90M | -6.55M | -9.25M | -6.32M |
| Capital Expenditure | -6.00K | -16.00K | -22.00K | -24.00K | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -16.00K | -22.00K | -24.00K | -20.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.33M | 2.79M | 683.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 0.00 | -1.10M |
| Other Financing Activities | -346.00K | -244.00K | -318.00K | -157.00K | 284.00K |
| Cash from Financing | 10.98M | 2.55M | 365.00K | -157.00K | -811.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.56M | -6.37M | -6.21M | -9.43M | -7.15M |